Skip to Main Content

Author Details

Raffaella Pippa
University of Navarra, Center for Applied Medical Research (CIMA)
2008
20
14
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
31593801A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.Cancer Lett2020
31858592Data mining analysis of the PP2A cell cycle axis in mesothelioma patients.J Cell Physiol2020
31913266A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia.Blood Cancer J2020
32922691Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells.J Extracell Vesicles2020
32839770SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.bioRxiv2020
32250729Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.J Urol2020
32110991The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias.Cells2020
30100187Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.Cell2018
27872192The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells.J Biol Chem2017
27092295Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia.Front Oncol2016
28903318MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia.Oncotarget2016
27705940Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.Oncotarget2016
25801305New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2.Mol Immunol2015
26310075Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.J Biomed Nanotechnol2015
25637054CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.Haematologica2015
24436473Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.Clin Cancer Res2014
25567395Importance of genetics in acute myeloid leukemia.An Sist Sanit Navar2014
24781014Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity.Leukemia2014
22179826p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.Oncogene2012
18064564Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.Breast Cancer Res Treat2008
  • 1 - 20 of 20

Recommended Authors

Ashok Kumar Jayavelu
German Cancer Research Center (DKFZ)
Career Start Year 2014
Number of shared co-authors 3
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Helen He Zhu
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Presha Rajbhandari
Columbia University
Career Start Year 2009
Number of shared co-authors 2
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 6
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 0
Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 4
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 2
Goutham Narla
The University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 6
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 3
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 1
Linda Z Penn
University of Toronto
Career Start Year 1990
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 2
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 4
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 5
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 8

Collaborators

Mar??a D Odero
University of Navarra
Co-authored papers 13
Dale J Christensen
TFF Pharmaceuticals, Inc.
Co-authored papers 3
Michael P Vitek
Duke University Medical Center
Co-authored papers 3
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Rosalie C Sears
Oregon Health and Science University
Co-authored papers 2
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 2
Nameeta P Richard
Randall Children's Hospital at Legacy Emanuel
Co-authored papers 1
Rabi Murad
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Jun Yin
Co-authored papers 1
David E Gordon
Emory University
Co-authored papers 1
Deanne Tibbitts
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Ashutosh K Tewari
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Ryan J Mackenzie
Oregon Health & Science University, USA [2] Knight Cancer Institute
Co-authored papers 1
Hyungsoo Kim
Sungkyunkwan University
Co-authored papers 1
Ana Dominguez Andres
Co-authored papers 1
Brian James
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Matthew D Galsky
Co-authored papers 1
Arnaud Besson
University of Toulouse, CNRS
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Shawn Mahmood
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Ronald E Gordon
Co-authored papers 1
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Nuria Lopez-Bigas
Universitat Pompeu Fabra
Co-authored papers 1
Bill H Chang
Oregon Health and Science University
Co-authored papers 1
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 1
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Peiyao Li
Fuzhou University
Co-authored papers 1
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Release 1.2